HIV血清状态对HbA1c有何影响?一项使用持续葡萄糖监测的前瞻性分析
在英国布莱顿诊所前瞻性招募60例HIV感染者和48例年龄、性别匹配的HIV阴性者,佩戴Dexcom G6持续葡萄糖监测最长10天,并行口服葡萄糖耐量试验测血糖、果糖胺及配对HbA1c。回归分析显示HIV血清状态对HbA1c无显著影响,结果支持将HbA1c纳入HIV感染者的常规临床血液检查。
要点
- HIV血清状态在回归模型中对HbA1c无显著影响。
- 研究纳入60例HIV感染者与48例HIV阴性者,两组均含2型糖尿病患者。
- 作者认为结果支持将HbA1c纳入HIV感染者的常规临床血液检查。
核心结论
- 作者对血糖进行了综合评估,未发现HIV血清状态影响HbA1c的强证据,结果支持将HbA1c纳入HIV感染者的常规临床血液检查。
研究设计与样本
- 前瞻性队列研究,从英国布莱顿的诊所特意招募60例HIV感染者及年龄、性别匹配的48例HIV阴性者。
- 每名参与者佩戴Dexcom G6持续葡萄糖监测最长10天,行口服葡萄糖耐量试验测血糖,并测果糖胺与配对HbA1c。
- 采用回归分析评估HIV对HbA1c的影响,并对持续葡萄糖监测血糖、静脉血糖和果糖胺分别建立模型。
- HIV感染者60例中90%为男性、50%患2型糖尿病、平均±标准差年龄57±10.7岁、100%病毒载量检测不到。
- 无HIV者48例中92%为男性、30%患2型糖尿病、平均年龄57.7±8.9岁。
主要发现
- 在回归模型内,HIV血清状态对HbA1c无显著影响。
临床怎么用
- 作者认为结果支持将HbA1c纳入HIV感染者的常规临床血液检查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Type 2 diabetes (T2D) is reported to be more common in people living with HIV (PLWH). Clinical guidelines recommend screening for diabetes in PLWH, but there is no agreed method due to studies reporting HbA1c is falsely low in PLWH. These studies were performed in the early HIV era when participants were taking older preparations of antiretroviral therapy that are rarely used today. We aimed to investigate whether HIV serostatus influences HbA1c. RESEARCH DESIGNS AND METHODS: We conducted a prospective cohort study of PLWH and age- and sex-matched HIV-negative participants who were purposely recruited from clinics in Brighton, U.K. Each participant wore a Dexcom G6 continuous glucose monitor (CGM) for up to 10 days, had glucose measured during an oral glucose tolerance test, and fructosamine and paired HbA1c were measured. We performed regression analysis to assess the influence of HIV on HbA1c and used a separate model for CGM glucose, venous glucose, and fructosamine. In addition, we included predictor variables used in previous studies that explored HbA1c discrepancy. RESULTS: We recruited 60 PLWH (90% men, 50% with T2D, mean ± SD age 57 ± 10.7 years, 100% undetectable viral load) and 48 people without HIV (92% men, 30% with T2D, mean age 57.7 ± 8.9 years). We found that HIV serostatus did not have a significant influence on HbA1c within the regression models. CONCLUSIONS: We performed a comprehensive assessment of glycemia to assess whether HIV serostatus influences HbA1c. We did not find any strong evidence that HIV serostatus influenced HbA1c. The results of our study support incorporating HbA1c into routine clinical blood work in PLWH.
引用
- Daultrey H, Oliver NS, Wright J, et al. What Is the Influence of HIV Serostatus on HbA1c? A Prospective Analysis Using Continuous Glucose Monitoring. Diabetes Care. 2024. PMID: 38805493. doi:10.2337/dc24-0225
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。